NCT02671890View on ClinicalTrials.gov

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

May 8, 2024

Study Completion Date

November 11, 2024

Conditions
Metastatic Pancreatic AdenocarcinomaRefractory Malignant Solid NeoplasmStage IV Pancreatic Cancer AJCC v8
Interventions
DRUG

Chemotherapy

DRUG

Disulfiram

Given PO

DRUG

Gemcitabine Hydrochloride

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (2)

55905

Mayo Clinic in Rochester, Rochester

56701

Sanford Thief River Falls Medical Center, Thief River Falls

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER